[临床实践中的CAR-T细胞疗法]
Tomoyasu Jo1,2
1Department of Hematology, Graduate School of Medicine, Kyoto University.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
化学抗原受体 (CAR) T细胞疗法在某些血液癌症中表现有前途. 这篇评论详细介绍了CAR T细胞疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法对复发性/耐药性B细胞恶性瘤有效.
- 五种CAR-T产品已获得批准,并在日本广泛使用.
- 卡特-T疗法涉及复杂的,多步骤的过程,需要优化.
研究的目的:
- 审查日本CAR T细胞疗法的当前临床应用.
- 讨论CAR T细胞治疗的实际考虑.
- 检查CAR T细胞疗法的作用与新兴治疗方法一起.
主要方法:
- 关于日本CAR T细胞治疗的当前临床实践和文献的综述.
- 治疗发送步骤的分析:T细胞采集,制造,桥接,输液和不良事件管理.
- 对CAR T细胞疗法的比较评估与其他新的治疗方案.
主要成果:
- 在日本,CAR T细胞疗法在特定的血液性恶性瘤中取得了显著的应用.
- 在CAR T细胞治疗的各个阶段,优化至关重要.
- 治疗后的管理和解决疾病复发是关键的挑战.
结论:
- 在日本,CAR T细胞疗法是某些血液癌症的重要治疗选择.
- 积累临床经验和治疗后护理的证据至关重要.
- 了解CAR T细胞治疗在不断发展的治疗方法中的地位,对于未来的策略至关重要.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
